China Fertility Services Market Research Report - Forecast till 2027

China Fertility Services Market Research Report: by Underlying Cause (Female Infertility, Male Infertility), by Treatment Type (Assistive Reproductive Technology (ART), Infertility Drugs), by End-user (Fertility Clinics, Clinical Research Institutes, Hospitals, Others) and Region - Forecast till 2027

ID: MRFR/HC/5690-HCR | February, 2021 | Region : Bric

Table of Content:
1 Executive Summary

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.3 List of Assumptions

2.4 Market Structure

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.3 Restraints

4.4 Opportunities

5 Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porter’s Five Forces Model

5.2.1 Threat of New Entrants

5.2.2 Bargaining Power of Suppliers

5.2.3 Bargaining Power of Buyers

5.2.4 Threat of Substitutes

5.2.5 Intensity of Rivalry

6 China Fertility Services Market, By Underlying Cause

6.1 Overview

6.1.1 Female Infertility

6.1.2 Male Infertility

7 China Fertility Services Market, By Treatment Type

7.1 Overview

7.1.1 Assisted Reproductive Technology (ART)

7.1.2 Infertility Drugs

8 China Fertility Services Market, By End User

8.1 Overview

8.1.1 Fertility Clinics

8.1.2 Hospitals

8.1.3 Clinical Research Institutes

8.1.4 Others

9 China Fertility Services Market, By Region

9.1 Overview

9.2 East China

9.3 South East China

9.4 West China

9.5 North China

9.6 Central China

10 Competitive Landscape

10.1 Competitive Scenario

10.1.1 Competitive Overview of the China Fertility Services Market

11 Company Profiles

11.1 Cook Medical

11.1.1 Company Overview

11.1.2 Financial Overview

11.1.3 Company Offering

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.1.6 Key Strategy

11.2 CooperSurgical

11.2.1 Company Overview

11.2.2 Financial Overview

11.2.3 Company Offering

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.2.6 Key Strategy

11.3 Ferring Pharmaceuticals

11.3.1 Company Overview

11.3.2 Financial Overview

11.3.3 Company Offering

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.3.6 Key Strategy

11.4 Irvine Scientific sales Company, Inc

11.4.1 Company Overview

11.4.2 Financial Overview

11.4.3 Company Offering

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.4.6 Key Strategy

11.5 Merck KGaA

11.5.1 Company Overview

11.5.2 Financial Overview

11.5.3 Company Offering

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.5.6 Key Strategy

11.6 Vitrolife

11.6.1 Company Overview

11.6.2 Financial Overview

11.6.3 Company Offering

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.6.6 Key Strategy

11.7 Others

12 Appendix

12.1 Discussion Blue Print

12.2 References



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.